FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2551043399> ?p ?o ?g. }

• W2551043399 abstract "Background The clinical presentation of ankylosing spondylitis (AS) can be different between genders. Objectives To investigate differences in clinical assessments of disease activity, physical function and quality of life between male and female AS patients before the start of TNF-α inhibitors and after 2 years of follow-up. Methods Patients from the Groningen Leeuwarden AS (GLAS) cohort who started TNF-α inhibitors because of active disease with baseline and 2-year follow-up visits were included. Disease activity was assessed using the BASDAI, ASDAS, CRP, and patient GDA. Physical function and quality of life were assessed using the BASFI and ASQoL, respectively. Results Of the 220 included AS patients with active disease, 69% were male, 78% HLA-B27 positive, mean age was 43±12 years, and median duration of symptoms 16 years (IQR 8–25). Patient characteristics were comparable between men and women. At baseline, female patients with AS experienced significantly higher disease activity according to BASDAI, ASDAS, and patient GDA compared to male patients. Baseline CRP levels were comparable between genders. Furthermore, physical function (BASFI) and quality of life (ASQoL) were significantly worse in female patients (Table 1). After staring TNF-α inhibitors, all clinical assessments improved significantly during 2 years of follow-up. The change over 2 years was comparable between male and female patients for all measures of disease activity, physical function, and quality of life (Table 1). After 2 years, significantly less women were still using their first TNF-α inhibitor (53% vs. 81%) and significantly more women had switched to a second TNF-α inhibitor (31% vs. 15%). Conclusions In this large cohort of AS patients with active disease, cross-sectional analysis showed that women experience higher disease activity and worse physical function and quality of life on self-reported assessments than men. Longitudinal analysis after starting TNF-α inhibitors showed that the changes in clinical assessments over 2 years were comparable between genders. Acknowledgement The GLAS cohort was supported by an unrestricted grant from Pfizer. Pfizer had no role in the design, conduct, interpretation, or publication of this study. Disclosure of Interest B. van der Slik: None declared, S. Arends Grant/research support from: Pfizer, E. Brouwer Grant/research support from: Pfizer, F. Wink Consultant for: Abbvie, M. Efde: None declared, H. Bootsma: None declared, F. Maas: None declared, A. Spoorenberg Grant/research support from: Abbvie, Pfizer, UCB, Consultant for: Abbvie, Pfizer, MSD, UCB, Novartis" @default.
• W2551043399 created "2016-11-30" @default.
• W2551043399 creator A5005994370 @default.
• W2551043399 creator A5044334265 @default.
• W2551043399 creator A5045187079 @default.
• W2551043399 creator A5046964429 @default.
• W2551043399 creator A5052491189 @default.
• W2551043399 creator A5057227498 @default.
• W2551043399 creator A5065705574 @default.
• W2551043399 creator A5084201150 @default.
• W2551043399 date "2016-06-01" @default.
• W2551043399 modified "2023-09-26" @default.
• W2551043399 title "SAT0419 Gender Differences in Disease Activity, Physical Function and Quality of Life in Patients with Ankylosing Spondylitis Treated with TNF-α Inhibitors" @default.
• W2551043399 doi "https://doi.org/10.1136/annrheumdis-2016-eular.3921" @default.
• W2551043399 hasPublicationYear "2016" @default.
• W2551043399 type Work @default.
• W2551043399 sameAs 2551043399 @default.
• W2551043399 citedByCount "0" @default.
• W2551043399 crossrefType "journal-article" @default.
• W2551043399 hasAuthorship W2551043399A5005994370 @default.
• W2551043399 hasAuthorship W2551043399A5044334265 @default.
• W2551043399 hasAuthorship W2551043399A5045187079 @default.
• W2551043399 hasAuthorship W2551043399A5046964429 @default.
• W2551043399 hasAuthorship W2551043399A5052491189 @default.
• W2551043399 hasAuthorship W2551043399A5057227498 @default.
• W2551043399 hasAuthorship W2551043399A5065705574 @default.
• W2551043399 hasAuthorship W2551043399A5084201150 @default.
• W2551043399 hasConcept C126322002 @default.
• W2551043399 hasConcept C159110408 @default.
• W2551043399 hasConcept C17991360 @default.
• W2551043399 hasConcept C1862650 @default.
• W2551043399 hasConcept C2776260265 @default.
• W2551043399 hasConcept C2777226972 @default.
• W2551043399 hasConcept C2777402515 @default.
• W2551043399 hasConcept C2777453003 @default.
• W2551043399 hasConcept C2779134260 @default.
• W2551043399 hasConcept C2779951463 @default.
• W2551043399 hasConcept C2780132546 @default.
• W2551043399 hasConcept C2780415856 @default.
• W2551043399 hasConcept C71924100 @default.
• W2551043399 hasConcept C72563966 @default.
• W2551043399 hasConceptScore W2551043399C126322002 @default.
• W2551043399 hasConceptScore W2551043399C159110408 @default.
• W2551043399 hasConceptScore W2551043399C17991360 @default.
• W2551043399 hasConceptScore W2551043399C1862650 @default.
• W2551043399 hasConceptScore W2551043399C2776260265 @default.
• W2551043399 hasConceptScore W2551043399C2777226972 @default.
• W2551043399 hasConceptScore W2551043399C2777402515 @default.
• W2551043399 hasConceptScore W2551043399C2777453003 @default.
• W2551043399 hasConceptScore W2551043399C2779134260 @default.
• W2551043399 hasConceptScore W2551043399C2779951463 @default.
• W2551043399 hasConceptScore W2551043399C2780132546 @default.
• W2551043399 hasConceptScore W2551043399C2780415856 @default.
• W2551043399 hasConceptScore W2551043399C71924100 @default.
• W2551043399 hasConceptScore W2551043399C72563966 @default.
• W2551043399 hasLocation W25510433991 @default.
• W2551043399 hasOpenAccess W2551043399 @default.
• W2551043399 hasPrimaryLocation W25510433991 @default.
• W2551043399 hasRelatedWork W2155462591 @default.
• W2551043399 hasRelatedWork W2315559539 @default.
• W2551043399 hasRelatedWork W2316669261 @default.
• W2551043399 hasRelatedWork W2321959062 @default.
• W2551043399 hasRelatedWork W2329853736 @default.
• W2551043399 hasRelatedWork W2410744257 @default.
• W2551043399 hasRelatedWork W2550566425 @default.
• W2551043399 hasRelatedWork W2552188862 @default.
• W2551043399 hasRelatedWork W2556127701 @default.
• W2551043399 hasRelatedWork W2754034395 @default.
• W2551043399 hasRelatedWork W2754206965 @default.
• W2551043399 hasRelatedWork W2755869208 @default.
• W2551043399 hasRelatedWork W2887617504 @default.
• W2551043399 hasRelatedWork W2953191327 @default.
• W2551043399 hasRelatedWork W3034029514 @default.
• W2551043399 hasRelatedWork W3035753961 @default.
• W2551043399 hasRelatedWork W3045439754 @default.
• W2551043399 hasRelatedWork W3049504795 @default.
• W2551043399 hasRelatedWork W3164792926 @default.
• W2551043399 hasRelatedWork W3209907291 @default.
• W2551043399 isParatext "false" @default.
• W2551043399 isRetracted "false" @default.
• W2551043399 magId "2551043399" @default.
• W2551043399 workType "article" @default.